Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival
- DOI
- 10.1016/j.jtct.2026.06.021
- Published
- 2026-06
- Container
- Transplantation and Cellular Therapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jtct.2026.06.021,
title = {Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival},
author = {Gurbakhash Kaur and Jennifer Logue and Ruta Brazauskas and Temitope Oloyede and Muhammad Bilal Abid and Sairah Ahmed and Mahmoud Aljurf and Rahul Banerjee and Asad Bashey and Amer M. Beitinjaneh and Natalie S. Callander and Paul Castillo and Bhagirathbhai Dholaria and Scott R. Goldsmith and Shahrukh Hashmi and Mohamed A. Kharfan-Dabaja and Hongtao Liu and Hira Mian and Taiga Nishihori and Kai Rejeski and Ayman Saad and Michael J. Slade and Cameron J. Turtle and Dan T. Vogl and Kirsten M. Williams and Baldeep Wirk and Marcelo C. Pasquini and Amy Moskop and Othman Salim Akhtar and Doris K. Hansen and Murali Janakiram},
year = {2026},
journal = {Transplantation and Cellular Therapy},
doi = {10.1016/j.jtct.2026.06.021},
url = {https://doi.org/10.1016/j.jtct.2026.06.021}
}RIS
TY - JOUR TI - Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival AU - Gurbakhash Kaur AU - Jennifer Logue AU - Ruta Brazauskas AU - Temitope Oloyede AU - Muhammad Bilal Abid AU - Sairah Ahmed AU - Mahmoud Aljurf AU - Rahul Banerjee AU - Asad Bashey AU - Amer M. Beitinjaneh AU - Natalie S. Callander AU - Paul Castillo AU - Bhagirathbhai Dholaria AU - Scott R. Goldsmith AU - Shahrukh Hashmi AU - Mohamed A. Kharfan-Dabaja AU - Hongtao Liu AU - Hira Mian AU - Taiga Nishihori AU - Kai Rejeski AU - Ayman Saad AU - Michael J. Slade AU - Cameron J. Turtle AU - Dan T. Vogl AU - Kirsten M. Williams AU - Baldeep Wirk AU - Marcelo C. Pasquini AU - Amy Moskop AU - Othman Salim Akhtar AU - Doris K. Hansen AU - Murali Janakiram PY - 2026 JO - Transplantation and Cellular Therapy DO - 10.1016/j.jtct.2026.06.021 UR - https://doi.org/10.1016/j.jtct.2026.06.021 ER -
APA
Kaur, G., Logue, J., Brazauskas, R., Oloyede, T., Abid, M. B., Ahmed, S., Aljurf, M., Banerjee, R., Bashey, A., Beitinjaneh, A. M., Callander, N. S., Castillo, P., Dholaria, B., Goldsmith, S. R., Hashmi, S., Kharfan-Dabaja, M. A., Liu, H., Mian, H., Nishihori, T., Rejeski, K., Saad, A., Slade, M. J., Turtle, C. J., Vogl, D. T., Williams, K. M., Wirk, B., Pasquini, M. C., Moskop, A., Akhtar, O. S., Hansen, D. K., & Janakiram, M. (2026). Prolonged Cytopenia After Idecabtagene Vicleucel for Multiple Myeloma is Associated with Poor Overall Survival. Transplantation and Cellular Therapy. https://doi.org/10.1016/j.jtct.2026.06.021
Source records
- crossref · retrieved 2026-09-26T07:19:03.717Z